BDBM106507 US8586579, 96

SMILES CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nc(C)cc3occc23)CC1

InChI Key InChIKey=QGKIQQCQAJMJNK-UHFFFAOYSA-N

Data  3 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 106507   

TargetD(3) dopamine receptor(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM106507(US8586579, 96)
Affinity DataKi:  4.64nMAssay Description:The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expr...More data for this Ligand-Target Pair
In DepthDetails
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM106507(US8586579, 96)
Affinity DataKi:  75.2nMAssay Description:The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expr...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetD(2) dopamine receptor(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM106507(US8586579, 96)
Affinity DataKi:  249nMAssay Description:The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expr...More data for this Ligand-Target Pair
In DepthDetails
US Patent